Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporotic women

Author： Hiligsmann Mickaël   Boonen Annelies   Dirksen Carmen D   Sedrine Wafa Ben   Reginster Jean-Yves  

Publisher： Informa Healthcare

ISSN： 1473-7167

Source： Expert Review of Pharmacoeconomics and Outcomes Research, Vol.13, Iss.1, 2013-02, pp. : 19-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of Post-Menopausal Osteoporotic Women in Belgium

By Hiligsmann Mickaël   Reginster Jean-Yves  

PharmacoEconomics, Vol. 29, Iss. 10, 2011-10 ,pp. : 895-911

Adis International

Access to resources Recommend Favorite

A Cost-Effectiveness Model of Tibolone as Treatment for the Prevention of Osteoporotic Fractures in Postmenopausal Women in Sweden

By Willis M.  

Clinical Drug Investigation, Vol. 21, Iss. 2, 2001-02 ,pp. : 115-127

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Letrozole in the Treatment of Advanced Breast Cancer in Postmenopausal Women in the UK

By Nuijten M.  

PharmacoEconomics, Vol. 16, Iss. 4, 1999-10 ,pp. : 379-397

Adis International

Access to resources Recommend Favorite

Denosumab for the Prevention of Osteoporotic Fractures in Post-Menopausal Women: A NICE Single Technology Appraisal

By Scotland Graham  

PharmacoEconomics, Vol. 29, Iss. 11, 2011-11 ,pp. : 951-961

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis

By Rosner A.J.  

PharmacoEconomics, Vol. 14, Iss. 5, 1998-11 ,pp. : 559-573

Adis International

Access to resources Recommend Favorite